AssayIndex
QSC cross-section

QSC by compound

QSC records split by compound, with the index-wide comparison for the same compound beside each one. 28 compounds, 350 records. Cells below n=3 print their raw values instead of a median.

28 compounds350 records
CompoundClassReportsQSC median %Index median %Δ (pp)SpecPass %
SemaglutideIncretin5699.2598.89+0.3697.0100
TirzepatideIncretin5099.3898.55+0.8397.0100
TB-500Tissue-repair4899.8099.53+0.2798.5100
CJC-1295 (no DAC)Growth-hormone3999.0399.09-0.0698.090
RetatrutideIncretin2899.0398.37+0.6696.5100
GHRP-6Growth-hormone1799.7799.54+0.2399.0100
Melanotan IIMelanocortin-receptor1399.8299.42+0.4098.5100
BPC-157Tissue-repair1299.5299.16+0.3698.0100
EpitalonShort1299.9199.56+0.3599.0100
MK-677 (Ibutamoren mesylate)Non-peptide1199.7499.49+0.2598.5100
SS-31 (Elamipretide)Metabolic998.4099.53-1.1398.544
AOD-9604Metabolic7 n=799.7099.29+0.4198.0100
Enclomiphene citrateNon-peptide6 n=699.7999.44+0.3498.5100
PT-141 (Bremelanotide)Melanocortin-receptor5 n=599.5599.38+0.1798.5100
Kisspeptin-10Melanocortin-receptor5 n=599.4999.28+0.2198.5100
PramlintideIncretin4 n=499.4499.10+0.3497.5100
ARA-290Tissue-repair4 n=499.6299.42+0.2098.0100
SelankNeuroactive3 n=399.9399.59+0.3499.0100
IpamorelinGrowth-hormone3 n=399.6099.47+0.1399.0100
SurvodutideIncretin3 n=398.3198.38-0.0796.5100
MOTS-cMetabolic3 n=399.9399.13+0.8098.0100
LiraglutideIncretin2 n=2n<399.0097.5100
PinealonShort2 n=2n<399.9399.0100
CJC-1295 with DACGrowth-hormone2 n=2n<398.9597.5100
L-Glutathione (reduced)Short2 n=2n<399.3398.5100
IGF-1 LR3Growth-hormone2 n=2n<398.2895.0100
TriptorelinHypothalamic1 n=1n<399.4198.5100
DihexaNeuroactive1 n=1n<399.6398.5100
97.698.098.498.899.399.7100.1SemaglutideSemaglutide: Q1 98.78, median 99.25, Q3 99.51, n=56n=56TirzepatideTirzepatide: Q1 98.98, median 99.38, Q3 99.82, n=50n=50TB-500TB-500: Q1 99.66, median 99.80, Q3 99.93, n=48outlier 99.17outlier 99.21n=48CJC-1295 (no DAC)CJC-1295 (no DAC): Q1 98.79, median 99.03, Q3 99.44, n=39outlier 97.74n=39RetatrutideRetatrutide: Q1 98.59, median 99.03, Q3 99.31, n=28n=28GHRP-6GHRP-6: Q1 99.73, median 99.77, Q3 99.93, n=17outlier 99.29n=17Melanotan IIMelanotan II: Q1 99.42, median 99.82, Q3 99.93, n=13n=13BPC-157BPC-157: Q1 99.43, median 99.52, Q3 99.80, n=12n=12EpitalonEpitalon: Q1 99.75, median 99.91, Q3 99.93, n=12n=12MK-677 (Ibutamoren me…MK-677 (Ibutamoren me…: Q1 99.64, median 99.74, Q3 99.79, n=11n=11SS-31 (Elamipretide)SS-31 (Elamipretide): Q1 98.10, median 98.40, Q3 98.91, n=9n=9AOD-9604AOD-9604: Q1 99.45, median 99.70, Q3 99.88, n=7n=7Enclomiphene citrateEnclomiphene citrate: Q1 99.71, median 99.79, Q3 99.90, n=6n=6PT-141 (Bremelanotide)PT-141 (Bremelanotide): Q1 99.44, median 99.55, Q3 99.86, n=5n=5 Purity (% area)
Figure. Distribution per compound where n ≥ 4. Rows are ordered by coverage, not by result.

Which of these lines QSC actually stocks

Coverage here reflects what has been submitted to the index, not what is on the catalogue. Qingdao Sigma Chemical Co., Ltd. lists considerably more than the 28 compounds above. Of those 28, 16 have been seen arriving from a domestic warehouse rather than as a cross-border consignment — that is the whole of what the index can say about which lines are held in regional stock, and it is a record of what was submitted, not a stock position. The catalogue and the current stock position are on the supplier's own site.

Browse the QSC catalogue at qingdaosigma.com →